Clinical Trials Browser

Thrombocythemia, Essential × lestaurtinib × Myeloid × Clear all

NCT00586651 2015-10-08

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential

NCT00668421 2014-11-26

CEP-701 (Lestaurtinib) in Myelofibrosis

Phase 1/2 Unknown

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis